(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.34%) $78.75
(-1.50%) $2.16
(0.03%) $2 331.90
(-0.09%) $27.59
(0.75%) $972.10
(0.05%) $0.929
(0.11%) $10.84
(0.05%) $0.796
(-0.01%) $91.33
Live Chart Being Loaded With Signals
Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders...
Stats | |
---|---|
今日成交量 | 22 321.00 |
平均成交量 | 33 930.00 |
市值 | 153.68M |
EPS | INR0 ( 2024-02-11 ) |
下一个收益日期 | ( INR0 ) 2024-05-27 |
Last Dividend | INR0 ( N/A ) |
Next Dividend | INR0 ( N/A ) |
P/E | -3.74 |
ATR14 | INR0.0630 (0.33%) |
音量 相关性
Ortin Laboratories 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Ortin Laboratories 相关性 - 货币/商品
Ortin Laboratories 财务报表
Annual | 2022 |
营收: | INR60.20M |
毛利润: | INR26.31M (43.70 %) |
EPS: | INR-0.0823 |
FY | 2022 |
营收: | INR60.20M |
毛利润: | INR26.31M (43.70 %) |
EPS: | INR-0.0823 |
FY | 2022 |
营收: | INR82.31M |
毛利润: | INR35.79M (43.48 %) |
EPS: | INR-0.500 |
FY | 2021 |
营收: | INR81.67M |
毛利润: | INR42.17M (51.63 %) |
EPS: | INR1.160 |
Financial Reports:
No articles found.
Ortin Laboratories
Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti diabetics, analgesics and antipyretics, anti biotic, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。